Corrigendum to: Computational Evaluation of ADMET Properties and Molecular Docking Studies of 1,2,4-oxadiazole Analogs as Potential Inhibitors of Prostate Cancer

<p>In the originally published article [1], reference number 61 in the reference list contained an incorrect DOI link. It has now been corrected, which leads to the accessible online search. </p> <p> The original article can be found online at: https://www.eurekaselect.com/article/150537 </p> <p> The specific correction details are as follows: </p> <p> Original: </p> <p> Incorrect Link: </p> <p> [61] Bezerra Morais PA, Barbosa Silva JA, Javarini CL. State-of-art on the synthesis of heterocyclic compounds targeting SARS-CoV-2. Curr Org Chem 2024; 29(8). http://dx.doi.org/0.2174/011385272824876240812075831 </p> <p> Corrected Link: </p> <p> [61] Bezerra Morais PA, Barbosa Silva JA, Javarini CL. State-of-art on the synthesis of heterocyclic compounds targeting SARS-CoV-2. Curr Org Chem 2024; 29(8). http://dx.doi.org/10.2174/0113852728248762240812075831 </p> <p> The article has been updated to reflect this correction. </p> <p> The authors apologize for any inconvenience caused to the readers.</p>